Guardian Pharmacy Services, Inc.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 9, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | During market hours | $351.80M | $0.34 | $0.29 |
| Q1 FY2026 Ended Mar 31, 2026 | May 6, 2026 | During market hours | $336.60M | $0.21 | $0.29 |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 11, 2026 | During market hours | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 10, 2025 | During market hours | $377.40M | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 11, 2025 | During market hours | $344.30M | $0.14 | $0.23 |
| Q1 FY2025 Ended Mar 31, 2025 | May 12, 2025 | During market hours | $329.30M | $0.15 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 3, 2025 | Before market open | $338.60M | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 12, 2024 | During market hours | $314.40M | $-2.00 | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | FY 2026 | $129.00M to $131.00M | Raised |
| Revenue | FY 2026 | $1.43B to $1.45B | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Guardian Pharmacy Services filed with the SEC
Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
Results of operations · EX-99.1 to Form 8-K
Guardian Pharmacy Services, Inc. Announces Leadership Transitions
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance
Results of operations · EX-99.1 to Form 8-K
Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026
Results of operations · EX-99.1 to Form 8-K
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Smarter Growth, Better Service January
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance
Results of operations · EX-99.1 to Form 8-K
“intends,” “plans,” “projects,” “estimates,” “contemplates,” “aims,” “continues,” “anticipates” and similar expressions. Although we believe that the
Regulation FD disclosure · EX-99.1 to Form 8-K
Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance
Results of operations · EX-99.1 to Form 8-K
Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Guardian Pharmacy Services, Inc. Announces Preliminary Fourth Quarter and Full Year 2024 Results;
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Disclaimer This presentation has been prepared by Guardian Pharmacy
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K